Bernard Peperstraete
Fundador en Acuamark Diagnostics, Inc. .
Perfil
Bernard M.
Peperstraete is the founder of Acuamark Diagnostics, Inc. He currently serves as a Director at Visum Pharma, Inc. His former positions include President, Chief Executive Officer & Director at ACT Biotech, Inc., Director at Potentia Pharmaceuticals, Inc., Director at Exosome Diagnostics, Inc., Deputy Director at Tan Tock Seng Hospital Pte Ltd., Partner at NGN Capital LLC, and Advisor at MASA Life Science Ventures.
He holds an MBA from Harvard University and a doctorate from Université Catholique de Louvain.
Cargos activos de Bernard Peperstraete
| Empresas | Cargo | Inicio |
|---|---|---|
Acuamark Diagnostics, Inc.
 Acuamark Diagnostics, Inc. Information Technology ServicesTechnology Services Acuamark Diagnostics, Inc. develops blood-based screening for early cancer. The company was founded by Francis Barany and Bernard peperstraete and is headquartered in New York, NY. | Fundador | - |
Visum Pharma, Inc.
 Visum Pharma, Inc. Pharmaceuticals: MajorHealth Technology Visum Pharma, Inc. provides therapeutics for neurodegenerative diseases. The company is based in Stamford, CT. The CEO of the company is William J. Gedale. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Bernard Peperstraete.
| Empresas | Cargo | Fin |
|---|---|---|
Potentia Pharmaceuticals, Inc.
 Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Director/Miembro de la Junta | - |
| Tan Tock Seng Hospital Pte Ltd. | Corporate Officer/Principal | - |
Exosome Diagnostics, Inc.
 Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Director/Miembro de la Junta | - |
ACT Biotech, Inc.
 ACT Biotech, Inc. Pharmaceuticals: MajorHealth Technology ACT Biotech, Inc. operates as a biopharmaceutical company which develops and commercializes targeted oral cancer drugs. The company was founded on February 15, 2008 and is headquartered in New York, NY. | Director Ejecutivo | - |
NGN Capital LLC
 NGN Capital LLC Investment ManagersFinance NGN Capital LLC (NGN Capital) is a venture capital firm founded in 2003 by Kenneth S. Abramowitz and William J. Gedale. The firm is headquartered in New York. | Inversor de Capital Privado | - |
Formación de Bernard Peperstraete.
| Université Catholique de Louvain | Doctorate Degree |
| Harvard University | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 8 |
|---|---|
MASA Life Science Ventures
 MASA Life Science Ventures Investment ManagersFinance MASA Life Science Ventures (MASA Life Science Venture) is a venture capital firm founded in 1994 by Andrew Sinclair Dunlop. The firm is headquartered in Bethesda, Maryland. | Finance |
NGN Capital LLC
NGN Capital LLC Investment ManagersFinance NGN Capital LLC (NGN Capital) is a venture capital firm founded in 2003 by Kenneth S. Abramowitz and William J. Gedale. The firm is headquartered in New York. | Finance |
ACT Biotech, Inc.
ACT Biotech, Inc. Pharmaceuticals: MajorHealth Technology ACT Biotech, Inc. operates as a biopharmaceutical company which develops and commercializes targeted oral cancer drugs. The company was founded on February 15, 2008 and is headquartered in New York, NY. | Health Technology |
Exosome Diagnostics, Inc.
Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Health Services |
| Tan Tock Seng Hospital Pte Ltd. | |
Potentia Pharmaceuticals, Inc.
Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Health Technology |
Acuamark Diagnostics, Inc.
Acuamark Diagnostics, Inc. Information Technology ServicesTechnology Services Acuamark Diagnostics, Inc. develops blood-based screening for early cancer. The company was founded by Francis Barany and Bernard peperstraete and is headquartered in New York, NY. | Technology Services |
Visum Pharma, Inc.
Visum Pharma, Inc. Pharmaceuticals: MajorHealth Technology Visum Pharma, Inc. provides therapeutics for neurodegenerative diseases. The company is based in Stamford, CT. The CEO of the company is William J. Gedale. | Health Technology |
- Bolsa de valores
- Insiders
- Bernard Peperstraete
